Skip to main content
Erschienen in: European Journal of Pediatrics 11/2018

28.07.2018 | Original Article

Body mass index at the presentation of premature adrenarche is associated with components of metabolic syndrome at puberty

verfasst von: Gamze Kaya, Zehra Yavas Abali, Firdevs Bas, Sukran Poyrazoglu, Feyza Darendeliler

Erschienen in: European Journal of Pediatrics | Ausgabe 11/2018

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to analyze the relationship between premature adrenarche (PA) and metabolic syndrome (MeS) parameters at presentation and during puberty. This study comprised 47 girls with PA. Age- and puberty-matched 22 healthy girls without PA were the control group. Patients were evaluated at admission (first evaluation) and later in puberty (second evaluation). Anthropometric measurements, lipid levels, and hormonal parameters were studied and oral glucose tolerance test was performed. Indices for insulin resistance (IR) were calculated. The study group was divided in subgroups according to body mass index (BMI) and compared with the control group. The age of the PA group at first evaluation was 8.0 ± 1.1 years; mean height SDS and BMI SDS were 0.4 ± 1.2 and 0.6 ± 0.9, respectively. Age of PA group at the second evaluation was 12.9 ± 2.4 years. Frequency of obesity and overweight was 14.9 and 23.4%. Dyslipidemia ratio was 28.3%. PA group had significantly higher BMI than controls. Mean insulin concentration was higher and mean glucose and FGIR were lower in PA group and also dyslipidemia ratio was 5.3 times higher in PA than controls (p = 0.040). In PA group, overweight/obese subjects had still higher BMI at second evaluation and also higher fasting glucose, insulin, HOMA-IR. However, PA children with exaggerated DHEAS concentrations compared to those without had similar BMI SDS, insulin sensitivity, and secretion indices and lipid profile at second evaluation. BMI SDS at first evaluation was positively correlated with HOMA-IR at puberty; however, there is no correlation between DHEAS at first evaluation and HOMA-IR at puberty.
Conclusion: BMI at adrenarche is more important than prepubertal adrogen concentrations such as DHEAS, while predicting the IR in puberty. Long-term follow-up of children supports the observation that PA per se may be related to IR; however, the risk increases with obesity.
What is Known:
• Premature adrenarche (PA) is receiving more attention as evidence emerges for a relation between early androgen excess and metabolic syndrome.
• The onset of the adrenal androgen production before 8 years in girls defined as PA. Pubarche, axillary hair, apocrine body odor, acne are typical phenotypic features of PA.
What is New:
• Body mass index at adrenarche is an important risk factor for development of insulin resistance in pubertal ages.
• Degree of dehydroepiandrosterone sulfate elevation was not shown as a risk factor for insulin resistance.
Literatur
1.
Zurück zum Zitat Apter D (1998) Endocrine and metabolic abnormalities in adolescence with a PCOS-like condition: consequences for adult reproduction. Trends Endocrinol Metab 9:58–61CrossRef Apter D (1998) Endocrine and metabolic abnormalities in adolescence with a PCOS-like condition: consequences for adult reproduction. Trends Endocrinol Metab 9:58–61CrossRef
2.
Zurück zum Zitat Bundak R, Furman A, Gunoz H, Darendeliler F, Bas F, Neyzi O (2006) Body mass index references for Turkish children. Acta Paediatr 95:194–198CrossRef Bundak R, Furman A, Gunoz H, Darendeliler F, Bas F, Neyzi O (2006) Body mass index references for Turkish children. Acta Paediatr 95:194–198CrossRef
3.
Zurück zum Zitat Corvalan C, Uauy R, Mericq V (2013) Obesity is positively associated with dehydroepiandrosterone sulfate concentrations at 7 year in Chilean children of normal birth weight. Am J Clin Nutr 97:318–325CrossRef Corvalan C, Uauy R, Mericq V (2013) Obesity is positively associated with dehydroepiandrosterone sulfate concentrations at 7 year in Chilean children of normal birth weight. Am J Clin Nutr 97:318–325CrossRef
4.
Zurück zum Zitat Ferran K, Paiva S, Ldos G, Mde PG, Guimarães MM (2011) Isolated premature pubarche: report of anthropometric and metabolic profile of a Brazilian cohort of girls. Horm Res Paediatr 75:367–373CrossRef Ferran K, Paiva S, Ldos G, Mde PG, Guimarães MM (2011) Isolated premature pubarche: report of anthropometric and metabolic profile of a Brazilian cohort of girls. Horm Res Paediatr 75:367–373CrossRef
5.
Zurück zum Zitat Güven A, Cinaz P, Bideci A (2005) Is premature adrenarche a risk factor for atherogenesis? Pediatr Int 47:20–25CrossRef Güven A, Cinaz P, Bideci A (2005) Is premature adrenarche a risk factor for atherogenesis? Pediatr Int 47:20–25CrossRef
6.
Zurück zum Zitat Hatipoglu N, Ozturk A, Mazicioglu MM, Kurtoglu S, Seyhan S, Lokoglu F (2008) Waist circumference percentiles for 7-to 17-year-old Turkish children and adolescents. Eur J Pediatr 167:383–389CrossRef Hatipoglu N, Ozturk A, Mazicioglu MM, Kurtoglu S, Seyhan S, Lokoglu F (2008) Waist circumference percentiles for 7-to 17-year-old Turkish children and adolescents. Eur J Pediatr 167:383–389CrossRef
7.
Zurück zum Zitat Ibanez L, Potau N, Virdis R, Zampolli M, Terzi C, Gussinye M (1993) Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. J Clin Endocrinol Metab 76:1599–1603PubMed Ibanez L, Potau N, Virdis R, Zampolli M, Terzi C, Gussinye M (1993) Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. J Clin Endocrinol Metab 76:1599–1603PubMed
8.
Zurück zum Zitat Ibanez L, Potau N, Chacon P, Pascual C, Carrascosa A (1998) Hyperinsulinaemia, dyslipaemia and cardiovascular risk in girls with a history of premature pubarche. Diabetologia 41:1057–1063CrossRef Ibanez L, Potau N, Chacon P, Pascual C, Carrascosa A (1998) Hyperinsulinaemia, dyslipaemia and cardiovascular risk in girls with a history of premature pubarche. Diabetologia 41:1057–1063CrossRef
9.
Zurück zum Zitat Ibáñez L, Ong K, de Zegher F, Marcos MV, del Rio L, Dunger D (2003) Fat distribution in non-obese girls with and without precocious pubarche: central adiposity related to insulinemia and androgenemia from pre-puberty to post-menarche. Clin Endocrinol 58:372–379CrossRef Ibáñez L, Ong K, de Zegher F, Marcos MV, del Rio L, Dunger D (2003) Fat distribution in non-obese girls with and without precocious pubarche: central adiposity related to insulinemia and androgenemia from pre-puberty to post-menarche. Clin Endocrinol 58:372–379CrossRef
10.
Zurück zum Zitat Ibanez LDR, Lopez-Bermejo A, Marcos MV (2009) Clinical spectrum of premature pubarche: links to metabolic syndrome and ovarian hyperandrogenism. Rev Endocr Metab Disord 10:63–76CrossRef Ibanez LDR, Lopez-Bermejo A, Marcos MV (2009) Clinical spectrum of premature pubarche: links to metabolic syndrome and ovarian hyperandrogenism. Rev Endocr Metab Disord 10:63–76CrossRef
11.
Zurück zum Zitat Ibanez L, Oberfield S, Witchel S, Auchus RJ, Chang RJ, Codner E, Dabaghao P, Darendeliler F (2017) An international consortium update: pathophysiology, diagnosis and treatment of polycystic ovarian syndrome in adolescence. Horm Res Paediatr 88:371–395CrossRef Ibanez L, Oberfield S, Witchel S, Auchus RJ, Chang RJ, Codner E, Dabaghao P, Darendeliler F (2017) An international consortium update: pathophysiology, diagnosis and treatment of polycystic ovarian syndrome in adolescence. Horm Res Paediatr 88:371–395CrossRef
12.
Zurück zum Zitat Idkowiak J, Lavery GG, Dhir V, Barrett TG, Stewart PM, Krone N, Arlt W (2011) Premature adrenarche: novel lessons from early onset androgen excess. Eur J Endocrinol 165:189–207CrossRef Idkowiak J, Lavery GG, Dhir V, Barrett TG, Stewart PM, Krone N, Arlt W (2011) Premature adrenarche: novel lessons from early onset androgen excess. Eur J Endocrinol 165:189–207CrossRef
13.
Zurück zum Zitat Kurtoglu S, Hatipoglu N, Mazicioglu M, Kendirici M, Keskin M, Kondolot M (2010) Insulin resistance in obese children and adolescents: HOMA-IR cut-off levels in the prepubertal and pubertal periods. J Clin Res Pediatr Endocrinol 2:100–106CrossRef Kurtoglu S, Hatipoglu N, Mazicioglu M, Kendirici M, Keskin M, Kondolot M (2010) Insulin resistance in obese children and adolescents: HOMA-IR cut-off levels in the prepubertal and pubertal periods. J Clin Res Pediatr Endocrinol 2:100–106CrossRef
14.
Zurück zum Zitat Likitmaskaul S, Cowell CT, Donaghue K, Kreutzmann DJ, Howard NJ, Blades B, Silink M (1995) ‘Exaggaretad adrenarche’ in children presenting with premature adrenarcahe. Clin Endocrinol 42:265–272CrossRef Likitmaskaul S, Cowell CT, Donaghue K, Kreutzmann DJ, Howard NJ, Blades B, Silink M (1995) ‘Exaggaretad adrenarche’ in children presenting with premature adrenarcahe. Clin Endocrinol 42:265–272CrossRef
15.
Zurück zum Zitat Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470CrossRef Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470CrossRef
16.
Zurück zum Zitat Metcalf MG, Skidmore DS, Lowry GF, Mackenzie JA (1983) Incidence of ovulation in the years after menarche. J Endocrinol 97:213–219CrossRef Metcalf MG, Skidmore DS, Lowry GF, Mackenzie JA (1983) Incidence of ovulation in the years after menarche. J Endocrinol 97:213–219CrossRef
17.
Zurück zum Zitat National Heart, Lung and blood institute (NHLBI) (2011) Expert panel on integrated pediatric guideline for cardiovascular health and risk reduction. Pediatrics 128:1–44CrossRef National Heart, Lung and blood institute (NHLBI) (2011) Expert panel on integrated pediatric guideline for cardiovascular health and risk reduction. Pediatrics 128:1–44CrossRef
18.
Zurück zum Zitat Neyzi O, Furman A, Bundak R, Gunoz H, Darendeliler F, Bas F (2006) Growth reference for Turkish children aged 6 to 18 years. Acta Paediatr 95:1635–1641CrossRef Neyzi O, Furman A, Bundak R, Gunoz H, Darendeliler F, Bas F (2006) Growth reference for Turkish children aged 6 to 18 years. Acta Paediatr 95:1635–1641CrossRef
19.
Zurück zum Zitat Oberfield SE, Sopher AB, Gerken AT (2011) Approach to the girl with early onset of pubic hair. J Clin Endocrinol Metab 96:1610–1622CrossRef Oberfield SE, Sopher AB, Gerken AT (2011) Approach to the girl with early onset of pubic hair. J Clin Endocrinol Metab 96:1610–1622CrossRef
20.
Zurück zum Zitat Program NHBPE (2005) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents: US Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute, National High Blood Pressure Education. Program Program NHBPE (2005) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents: US Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute, National High Blood Pressure Education. Program
21.
Zurück zum Zitat Rosenfield RL (2007) Identifying children at risk for polycystic ovary syndrome. J Clin Endocrinol Metab 92:787–796CrossRef Rosenfield RL (2007) Identifying children at risk for polycystic ovary syndrome. J Clin Endocrinol Metab 92:787–796CrossRef
22.
Zurück zum Zitat Rosenfield RL, Cooke DW, Radovick S Puberty and its disorders in the female. In: Sperling MA (ed) Pediatric endocrinology, 4th edn. Elsevier Saunders, Philadelphia, p 2014CrossRef Rosenfield RL, Cooke DW, Radovick S Puberty and its disorders in the female. In: Sperling MA (ed) Pediatric endocrinology, 4th edn. Elsevier Saunders, Philadelphia, p 2014CrossRef
23.
Zurück zum Zitat Rotterdam E, ASRM-Sponsored P (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41–47CrossRef Rotterdam E, ASRM-Sponsored P (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41–47CrossRef
24.
Zurück zum Zitat Saenger P, Czernichow P, Hughes I, Reiter EO (2007) Small for gestational age: short stature and beyond. Endocr Rev 28:219–251CrossRef Saenger P, Czernichow P, Hughes I, Reiter EO (2007) Small for gestational age: short stature and beyond. Endocr Rev 28:219–251CrossRef
25.
Zurück zum Zitat Ten S, Maclaren N (2004) Insulin resistance syndrome in children. J Clin Endocrinol Metab 89:2526–2539CrossRef Ten S, Maclaren N (2004) Insulin resistance syndrome in children. J Clin Endocrinol Metab 89:2526–2539CrossRef
26.
Zurück zum Zitat Utriainen P, Jääskeläinen J, Romppanen J, Voutilainen R (2007) Childhood metabolic syndrome and its components in premature adrenarche. J Clin Endocrinol Metab 92:4282–4285CrossRef Utriainen P, Jääskeläinen J, Romppanen J, Voutilainen R (2007) Childhood metabolic syndrome and its components in premature adrenarche. J Clin Endocrinol Metab 92:4282–4285CrossRef
27.
Zurück zum Zitat Williams RM, Ward CE, Hughes IA (2012) Premature adrenarche. Arch Dis Child 97:250–254CrossRef Williams RM, Ward CE, Hughes IA (2012) Premature adrenarche. Arch Dis Child 97:250–254CrossRef
28.
Zurück zum Zitat Witchell SF (2006) Puberty and polycystic ovary syndrome. Mol Cell Endocrinol 254-255:146–153CrossRef Witchell SF (2006) Puberty and polycystic ovary syndrome. Mol Cell Endocrinol 254-255:146–153CrossRef
29.
Zurück zum Zitat Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S, Wong G, Bennett P, Shaw J, Caprio S (2007) IDF consensus group. The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes 8:299–306CrossRef Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S, Wong G, Bennett P, Shaw J, Caprio S (2007) IDF consensus group. The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes 8:299–306CrossRef
Metadaten
Titel
Body mass index at the presentation of premature adrenarche is associated with components of metabolic syndrome at puberty
verfasst von
Gamze Kaya
Zehra Yavas Abali
Firdevs Bas
Sukran Poyrazoglu
Feyza Darendeliler
Publikationsdatum
28.07.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Pediatrics / Ausgabe 11/2018
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-018-3211-1

Weitere Artikel der Ausgabe 11/2018

European Journal of Pediatrics 11/2018 Zur Ausgabe

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.